{
  "meta": {
    "name": "PsyAccess Trials Index — psychedelic therapy trials recruiting in Europe",
    "version": "1.0",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "attribution": "PsyAccess Trials Index, psyaccess.health/guides/psychedelic-trials-recruiting-europe/ (CC BY 4.0)",
    "updated": "2026-09-07",
    "next_verification": "2026-10-07",
    "recruiting": 47,
    "countries": 19,
    "authorised_not_yet_recruiting": 16
  },
  "trials": [
    {
      "id": "2025-525069-65-00",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2025-525069-65-00",
      "title": "ERPPAD - Efficacy in Relapse Prevention: Psilocybin in Alcohol use disorder with Depressive symptoms",
      "substance": "psilocybin",
      "phase": "Phase III",
      "conditions": "Alcohol use disorder, depressive symptoms",
      "countries": [
        "France"
      ],
      "sites": [
        {
          "name": "Centre Hospitalier Universitaire De Bordeaux",
          "city": "Pessac Cedex",
          "psyaccess_url": "https://psyaccess.health/providers/centre-hospitalier-universitaire-de-bordeaux/"
        },
        {
          "name": "Centre Hospitalier de la Côte Basque",
          "city": "Bayonne",
          "psyaccess_url": "https://psyaccess.health/providers/centre-hospitalier-de-la-cote-basque/"
        },
        {
          "name": "CHU Besançon",
          "city": "Besançon",
          "psyaccess_url": "https://psyaccess.health/providers/chu-besancon/"
        },
        {
          "name": "CHU de Bordeaux",
          "city": "Bordeaux",
          "psyaccess_url": "https://psyaccess.health/providers/chu-de-bordeaux/"
        },
        {
          "name": "CHU Brest",
          "city": "Brest",
          "psyaccess_url": "https://psyaccess.health/providers/chu-brest/"
        },
        {
          "name": "CH Le Vinatier",
          "city": "Bron",
          "psyaccess_url": "https://psyaccess.health/providers/ch-le-vinatier/"
        },
        {
          "name": "CHU de Nantes",
          "city": "Nantes",
          "psyaccess_url": "https://psyaccess.health/providers/chu-de-nantes/"
        },
        {
          "name": "CHU de Nîmes",
          "city": "Nîmes",
          "psyaccess_url": "https://psyaccess.health/providers/chu-de-nimes/"
        },
        {
          "name": "CHU Saint-Etienne",
          "city": "Saint-Priest",
          "psyaccess_url": "https://psyaccess.health/providers/chu-saint-etienne/"
        }
      ],
      "decision_date": "FR: 05/06/2026"
    },
    {
      "id": "NCT06793397",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT06793397",
      "title": "A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder",
      "substance": "psilocybin",
      "phase": "Phase III",
      "conditions": null,
      "countries": [
        "Czechia",
        "Germany",
        "Greece",
        "Ireland",
        "Poland",
        "United Kingdom"
      ],
      "sites": [
        {
          "name": "Institute of neuropsychiatric Care (INEP)",
          "city": "Prague",
          "psyaccess_url": "https://psyaccess.health/providers/institute-of-neuropsychiatric-care-inep/"
        },
        {
          "name": "Psyon s.r.o.",
          "city": "Prague",
          "psyaccess_url": "https://psyaccess.health/providers/psyon-s-r-o/"
        },
        {
          "name": "A-SHINE s.r.o.",
          "city": "Předměstí",
          "psyaccess_url": "https://psyaccess.health/providers/a-shine-s-r-o/"
        },
        {
          "name": "Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes",
          "city": "Homburg",
          "psyaccess_url": "https://psyaccess.health/providers/universitatsklinikum-des-saarlandes-und-medizinische-fakultat-der-universitat-de/"
        },
        {
          "name": "Charité Universitaetsmedizin Berlin",
          "city": "Berlin",
          "psyaccess_url": "https://psyaccess.health/providers/charite-universitaetsmedizin-berlin/"
        },
        {
          "name": "University Hospital Frankfurt",
          "city": "Frankfurt am Main",
          "psyaccess_url": "https://psyaccess.health/providers/university-hospital-frankfurt/"
        },
        {
          "name": "Central Institute of Mental Health",
          "city": "Mannheim",
          "psyaccess_url": "https://psyaccess.health/providers/central-institute-of-mental-health/"
        },
        {
          "name": "Eginitio Hospital",
          "city": "Athens",
          "psyaccess_url": "https://psyaccess.health/providers/eginitio-hospital/"
        },
        {
          "name": "Attikon University Hospital",
          "city": "Athens",
          "psyaccess_url": "https://psyaccess.health/providers/attikon-university-hospital/"
        },
        {
          "name": "Papageorgiou General Hospital",
          "city": "Thessaloniki",
          "psyaccess_url": "https://psyaccess.health/providers/papageorgiou-general-hospital/"
        },
        {
          "name": "Sheaf House - Tallaght Adult Mental Health Service",
          "city": "Dublin",
          "psyaccess_url": "https://psyaccess.health/providers/sheaf-house-tallaght-adult-mental-health-service/"
        },
        {
          "name": "La Nua Day Hospital Mental Health Centre",
          "city": "Galway",
          "psyaccess_url": "https://psyaccess.health/providers/la-nua-day-hospital-mental-health-centre/"
        },
        {
          "name": "Uniwersytecki Szpital Kliniczny W Białymstoku",
          "city": "Białystok",
          "psyaccess_url": "https://psyaccess.health/providers/uniwersytecki-szpital-kliniczny-w-bialymstoku-bialystok/"
        },
        {
          "name": "Promente - Centrum Neurologii i Psychogeriatrii w Bydgoszczy",
          "city": "Bydgoszcz",
          "psyaccess_url": "https://psyaccess.health/providers/promente-centrum-neurologii-i-psychogeriatrii-w-bydgoszczy/"
        },
        {
          "name": "UCK",
          "city": "Gdańsk",
          "psyaccess_url": "https://psyaccess.health/providers/uck/"
        },
        {
          "name": "Centrum Badan Klinicznych PI-House Sp. z o.o",
          "city": "Gdańsk",
          "psyaccess_url": "https://psyaccess.health/providers/centrum-badan-klinicznych-pi-house-sp-z-o-o/"
        },
        {
          "name": "MTZ Clinical Research Powered by Pratia",
          "city": "Warsaw",
          "psyaccess_url": "https://psyaccess.health/providers/mtz-clinical-research-powered-by-pratia/"
        },
        {
          "name": "Department of Pharmacology and Physiology of CNS",
          "city": "Warsaw",
          "psyaccess_url": "https://psyaccess.health/providers/department-of-pharmacology-and-physiology-of-cns/"
        },
        {
          "name": "Cambridge University Hospital NHS",
          "city": "Cambridge",
          "psyaccess_url": "https://psyaccess.health/providers/cambridge-university-hospital-nhs/"
        },
        {
          "name": "Clerkenwell Health - Doncaster",
          "city": "Doncaster",
          "psyaccess_url": "https://psyaccess.health/providers/clerkenwell-health-doncaster/"
        },
        {
          "name": "NHS Research Scotland",
          "city": "Edinburgh",
          "psyaccess_url": "https://psyaccess.health/providers/nhs-research-scotland/"
        },
        {
          "name": "Queen Elizabeth University Hospital",
          "city": "Glasgow",
          "psyaccess_url": "https://psyaccess.health/providers/queen-elizabeth-university-hospital/"
        },
        {
          "name": "St Pancras Clinical Research",
          "city": "London",
          "psyaccess_url": "https://psyaccess.health/providers/st-pancras-clinical-research/"
        },
        {
          "name": "King's College London",
          "city": "London",
          "psyaccess_url": "https://psyaccess.health/providers/king-s-college-london/"
        },
        {
          "name": "Clerkenwell Health - Welbeck Street",
          "city": "London",
          "psyaccess_url": "https://psyaccess.health/providers/clerkenwell-health-welbeck-street/"
        },
        {
          "name": "Re:Cognition Health",
          "city": "London",
          "psyaccess_url": "https://psyaccess.health/providers/re-cognition-health/"
        },
        {
          "name": "Clerkenwell Health - Baker Street",
          "city": "London",
          "psyaccess_url": "https://psyaccess.health/providers/clerkenwell-health-baker-street/"
        },
        {
          "name": "Wolfson Unit - Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust",
          "city": "Newcastle upon Tyne",
          "psyaccess_url": "https://psyaccess.health/providers/wolfson-unit-cumbria-northumberland-tyne-and-wear-nhs-foundation-trust/"
        },
        {
          "name": "Ascend Clinical Research",
          "city": "Reading",
          "psyaccess_url": "https://psyaccess.health/providers/ascend-clinical-research/"
        },
        {
          "name": "Sheffield Health and Social Care NHS Foundation Trust",
          "city": "Sheffield",
          "psyaccess_url": "https://psyaccess.health/providers/sheffield-health-and-social-care-nhs-foundation-trust/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "2023-505532-35-00",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2023-505532-35-00",
      "title": "CAPSI - Cancer related major depression treated with a single dose of psilocybin - a multicenter randomized placebo controlled double blind clinical trial",
      "substance": "psilocybin",
      "phase": "Phase II",
      "conditions": "Major Depressive Disorder, Malignant tumours ICD 10 C00 to C97",
      "countries": [
        "Sweden"
      ],
      "sites": [],
      "decision_date": "SE: 16/11/2023"
    },
    {
      "id": "2023-510488-36-01",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2023-510488-36-01",
      "title": "PsyPal; Psilocybin Therapy for Psychological Distress in Palliative Patients",
      "substance": "psilocybin",
      "phase": "Phase II",
      "conditions": "Chronic obstructive pulmonary disease (COPD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and atypical Parkinson disorder (APD), particularly multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal syndrome (CBS).",
      "countries": [
        "Czechia",
        "Denmark",
        "Netherlands",
        "Portugal"
      ],
      "sites": [
        {
          "name": "University Medical Center Groningen (UMCG) — PsyPal trial site",
          "city": "Groningen",
          "psyaccess_url": "https://psyaccess.health/providers/university-medical-center-groningen-umcg-psypal-trial-site/"
        },
        {
          "name": "National Institute of Mental Health",
          "city": "Prague",
          "psyaccess_url": "https://psyaccess.health/providers/national-institute-of-mental-health/"
        },
        {
          "name": "Bispebjerg Hospital",
          "city": "Copenhagen",
          "psyaccess_url": "https://psyaccess.health/providers/bispebjerg-hospital/"
        },
        {
          "name": "Champalimaud Foundation",
          "city": "Lisbon",
          "psyaccess_url": "https://psyaccess.health/providers/champalimaud-foundation/"
        }
      ],
      "decision_date": "NL: 25/11/2024, DK: 20/11/2024, CZ: 20/11/2024, PT: 25/11/2024"
    },
    {
      "id": "2024-512911-34-00",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2024-512911-34-00",
      "title": "Efficacy of psilocybin and trazodone combination in treatment-resistant depression: a randomized controlled proof-of-concept study (PSILOTRAZ)",
      "substance": "psilocybin",
      "phase": "Phase II",
      "conditions": "Treatment-resistant depression",
      "countries": [
        "France"
      ],
      "sites": [
        {
          "name": "GHU St Anne Psychiatrie et Neurosciences",
          "city": "Paris",
          "psyaccess_url": "https://psyaccess.health/providers/ghu-st-anne-psychiatrie-et-neurosciences/"
        }
      ],
      "decision_date": "FR: 13/06/2025"
    },
    {
      "id": "2024-516936-93-02",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2024-516936-93-02",
      "title": "Soothing Pain After ChEmotherapy: Psilocybin As INtervention (SPACE-PAIN) — a randomized controlled pilot trial",
      "substance": "psilocybin",
      "phase": "Phase II",
      "conditions": "chemotherapy-induced peripheral neuropathy, chronic neuropathic pain",
      "countries": [
        "Netherlands"
      ],
      "sites": [],
      "decision_date": "NL: 08/01/2025"
    },
    {
      "id": "2024-517747-31-00",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2024-517747-31-00",
      "title": "Psilocybin - a  strategy of rapid antidepressant response in depression comorbid with cancer,a randomized double-blind study with the possibility of entering open extension",
      "substance": "psilocybin",
      "phase": "Phase II",
      "conditions": "Depressive disorder comorbid with cancer",
      "countries": [
        "Czechia"
      ],
      "sites": [
        {
          "name": "Narodni Ustav Dusevniho Zdravi",
          "city": "Klecany",
          "psyaccess_url": "https://psyaccess.health/providers/narodni-ustav-dusevniho-zdravi/"
        },
        {
          "name": "Masarykuv Onkologicky Ustav",
          "city": "Brno-Stred",
          "psyaccess_url": "https://psyaccess.health/providers/masarykuv-onkologicky-ustav/"
        }
      ],
      "decision_date": "CZ: 11/11/2024"
    },
    {
      "id": "2024-517902-27-00",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2024-517902-27-00",
      "title": "Regression of Atherosclerosis induced by liFe chAnging Experience with psiLocybin",
      "substance": "psilocybin",
      "phase": "Phase II",
      "conditions": "Stable Ischemic Heart Disease",
      "countries": [
        "Czechia"
      ],
      "sites": [],
      "decision_date": "CZ: 21/11/2024"
    },
    {
      "id": "2024-518061-10-00",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2024-518061-10-00",
      "title": "Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)Cognitive Mechanisms",
      "substance": "psilocybin",
      "phase": "Phase II",
      "conditions": "Severe Alcohol Use Disorder",
      "countries": [
        "Belgium"
      ],
      "sites": [],
      "decision_date": "BE: 29/01/2025"
    },
    {
      "id": "2024-518218-24-00",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2024-518218-24-00",
      "title": "A double-blind, randomized, controlled trial on the effect of PEX010 for prolonged grief disorder",
      "substance": "psilocybin",
      "phase": "Phase II",
      "conditions": "Prolonged grief disorder",
      "countries": [
        "Sweden"
      ],
      "sites": [],
      "decision_date": "SE: 10/02/2025"
    },
    {
      "id": "2024-519844-34-03",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2024-519844-34-03",
      "title": "Advancing PRecise Interventions for resistant DEpression: rebalancing brain networks and investigating the trajectories of antidepressant effect with psilocybin and personalized neuromodulation (PRIDE)",
      "substance": "psilocybin",
      "phase": "Phase II",
      "conditions": "Treatment Resistant Depression (TRD)",
      "countries": [
        "Italy"
      ],
      "sites": [
        {
          "name": "Universita' Degli Studi G. D'Annunzio Di Chieti",
          "city": "Chieti Scalo",
          "psyaccess_url": "https://psyaccess.health/providers/universita-degli-studi-g-d-annunzio-di-chieti/"
        },
        {
          "name": "ASL Roma 5",
          "city": "Colleferro (RM)",
          "psyaccess_url": "https://psyaccess.health/providers/asl-roma-5/"
        },
        {
          "name": "Azienda Ospedaliero Universitaria - Policlinico Riuniti Foggia",
          "city": "Foggia",
          "psyaccess_url": "https://psyaccess.health/providers/azienda-ospedaliero-universitaria-policlinico-riuniti-foggia/"
        }
      ],
      "decision_date": "IT: 08/07/2025"
    },
    {
      "id": "2025-523346-27-00",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2025-523346-27-00",
      "title": "A phase IIa open-label dose-finding study with lead-in phase evaluating the safety, pharmacokinetics, and attenuating effects of trazodone on the consciousness-altering effects of psilocybin in individuals with Treatment-Resistant Depression",
      "substance": "psilocybin",
      "phase": "Phase II",
      "conditions": "Treatment-Resistant Depression",
      "countries": [
        "Italy"
      ],
      "sites": [],
      "decision_date": "IT: 14/08/2026"
    },
    {
      "id": "NCT06319378",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT06319378",
      "title": "Cancer Related Major Depression Treated With a Single Dose of Psilocybin",
      "substance": "psilocybin",
      "phase": "Phase II",
      "conditions": null,
      "countries": [
        "Sweden"
      ],
      "sites": [
        {
          "name": "region Västra Götaland",
          "city": "Gothenburg",
          "psyaccess_url": "https://psyaccess.health/providers/region-vastra-gotaland/"
        },
        {
          "name": "Norra Stockholms Psykiatri",
          "city": "Stockholm",
          "psyaccess_url": "https://psyaccess.health/providers/norra-stockholms-psykiatri/"
        },
        {
          "name": "Psykiatriska Kliniken, Akademiska Sjukhuset",
          "city": "Uppsala",
          "psyaccess_url": "https://psyaccess.health/providers/psykiatriska-kliniken-akademiska-sjukhuset/"
        },
        {
          "name": "Örebro sjukhus",
          "city": "Örebro",
          "psyaccess_url": "https://psyaccess.health/providers/orebro-sjukhus/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT06378229",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT06378229",
      "title": "Psilocybin for Hospitalized Patients with Treatment-resistant Depression",
      "substance": "psilocybin",
      "phase": "Phase II",
      "conditions": null,
      "countries": [
        "Belgium"
      ],
      "sites": [
        {
          "name": "Ghent University Hospital",
          "city": "Ghent",
          "psyaccess_url": "https://psyaccess.health/providers/ghent-university-hospital/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT07169747",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT07169747",
      "title": "Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support",
      "substance": "psilocybin",
      "phase": "Phase II",
      "conditions": null,
      "countries": [
        "Sweden"
      ],
      "sites": [
        {
          "name": "Psykiatrikliniken, Baravägen 1",
          "city": "Lund",
          "psyaccess_url": "https://psyaccess.health/providers/psykiatrikliniken-baravagen-1/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "2024-517497-17-01",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2024-517497-17-01",
      "title": "Can a one-off administration of psilocybin reduce alcohol intake in patients with alcohol use disorder? A randomized, double-blinded, placebo-controlled clinical trial.",
      "substance": "psilocybin",
      "phase": "Phase I/II",
      "conditions": "Alcohol Use Disorder",
      "countries": [
        "Denmark"
      ],
      "sites": [],
      "decision_date": "DK: 14/11/2024"
    },
    {
      "id": "2023-503617-30-02",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2023-503617-30-02",
      "title": "Boosting recovery through excitation of arousal and awareness in comatose patients: Dose finding study (BREA2KTHROUGH DOSEFINDER)",
      "substance": "psilocybin",
      "phase": "Phase I",
      "conditions": "Coma and other disorders of consciousness due to acute traumatic and non-traumatic brain injury",
      "countries": [
        "Denmark"
      ],
      "sites": [],
      "decision_date": "DK: 28/05/2024"
    },
    {
      "id": "NCT03289949",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT03289949",
      "title": "The Neurobiological Effect of 5-HT2AR Modulation",
      "substance": "psilocybin",
      "phase": "Phase I",
      "conditions": null,
      "countries": [
        "Denmark"
      ],
      "sites": [
        {
          "name": "Neurobiology Research Unit, Rigshospitalet",
          "city": "Copenhagen",
          "psyaccess_url": "https://psyaccess.health/providers/neurobiology-research-unit-rigshospitalet/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT06796361",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT06796361",
      "title": "Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness",
      "substance": "psilocybin",
      "phase": "Phase I",
      "conditions": null,
      "countries": [
        "Switzerland"
      ],
      "sites": [
        {
          "name": "Clinical Trial Unit",
          "city": "Basel",
          "psyaccess_url": "https://psyaccess.health/providers/clinical-trial-unit/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT06798636",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT06798636",
      "title": "PsiloIMAGINE: A Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm",
      "substance": "psilocybin",
      "phase": "Phase I",
      "conditions": null,
      "countries": [
        "United Kingdom"
      ],
      "sites": [
        {
          "name": "Imperial College London",
          "city": "London",
          "psyaccess_url": "https://psyaccess.health/providers/imperial-college-london/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT06815653",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT06815653",
      "title": "Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs",
      "substance": "psilocybin",
      "phase": "Phase I",
      "conditions": null,
      "countries": [
        "United Kingdom"
      ],
      "sites": [
        {
          "name": "University College London",
          "city": "London",
          "psyaccess_url": "https://psyaccess.health/providers/university-college-london/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT06899334",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT06899334",
      "title": "Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy Participan",
      "substance": "psilocybin",
      "phase": "Phase I",
      "conditions": null,
      "countries": [
        "Switzerland"
      ],
      "sites": [
        {
          "name": "Clinical Pharmacology & Toxicology, University Hospital Basel",
          "city": "Basel",
          "psyaccess_url": "https://psyaccess.health/providers/clinical-pharmacology-toxicology-university-hospital-basel/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT07490353",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT07490353",
      "title": "Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects",
      "substance": "psilocybin",
      "phase": "Phase I",
      "conditions": null,
      "countries": [
        "Austria"
      ],
      "sites": [
        {
          "name": "Medical University of Vienna, Department of Psychiatry and Psychotherapy, Division of General Psychiatry",
          "city": "Vienna",
          "psyaccess_url": "https://psyaccess.health/providers/medical-university-of-vienna-department-of-psychiatry-and-psychotherapy-division/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT06368492",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT06368492",
      "title": "The Impact of Psilocybin on Pain in Fibromyalgia Patients",
      "substance": "psilocybin",
      "phase": "",
      "conditions": null,
      "countries": [
        "Netherlands"
      ],
      "sites": [
        {
          "name": "Maastricht University",
          "city": "Maastricht",
          "psyaccess_url": "https://psyaccess.health/providers/maastricht-university/"
        },
        {
          "name": "Leiden University Medical Center",
          "city": "Leiden",
          "psyaccess_url": "https://psyaccess.health/providers/leiden-university-medical-center/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "2023-508229-28-00",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2023-508229-28-00",
      "title": "High-Intensity Inpatient MDMA-Assisted Psychotherapy for Treatment-Refractory Posttraumatic Stress Disorder: An Open-Label Pilot Study",
      "substance": "mdma",
      "phase": "Phase II",
      "conditions": "posttraumatic stress disorder",
      "countries": [
        "Netherlands"
      ],
      "sites": [
        {
          "name": "Arq National Psychotrauma Centre",
          "city": "Diemen",
          "psyaccess_url": "https://psyaccess.health/providers/arq-national-psychotrauma-centre/"
        }
      ],
      "decision_date": "NL: 18/04/2024"
    },
    {
      "id": "NCT07494214",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT07494214",
      "title": "Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Pa",
      "substance": "mdma",
      "phase": "Phase I",
      "conditions": null,
      "countries": [
        "Switzerland"
      ],
      "sites": [
        {
          "name": "Clinical Pharmacology & Toxicology, University Hospital Basel",
          "city": "Basel",
          "psyaccess_url": "https://psyaccess.health/providers/clinical-pharmacology-toxicology-university-hospital-basel/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT06789705",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT06789705",
      "title": "Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficie",
      "substance": "mdma",
      "phase": "",
      "conditions": null,
      "countries": [
        "Switzerland"
      ],
      "sites": [
        {
          "name": "University Hospital Basel",
          "city": "Basel",
          "psyaccess_url": "https://psyaccess.health/providers/university-hospital-basel/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "2023-506597-12-00",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2023-506597-12-00",
      "title": "MOODBOOSTER«  Early efficacy of ketamine compared to placebo, in add-on therapy of venlafaxine for inpatients with severe unipolar major depressive episodes: a double blind randomized controlled trial »",
      "substance": "ketamine",
      "phase": "Phase III",
      "conditions": "Major depressive disorder with current severe major depressive episode",
      "countries": [
        "France"
      ],
      "sites": [
        {
          "name": "Bicetre Hospital",
          "city": "Le Kremlin Bicetre Cedex",
          "psyaccess_url": "https://psyaccess.health/providers/bicetre-hospital/"
        },
        {
          "name": "Commissariat A L'energie Atomique Et Aux Energies Alternatives",
          "city": "Orsay Cedex",
          "psyaccess_url": "https://psyaccess.health/providers/commissariat-a-l-energie-atomique-et-aux-energies-alternatives/"
        },
        {
          "name": "Etablissement Public De Sante Barthelemy Durand",
          "city": "Etampes Cedex",
          "psyaccess_url": "https://psyaccess.health/providers/etablissement-public-de-sante-barthelemy-durand/"
        }
      ],
      "decision_date": "FR: 27/06/2024"
    },
    {
      "id": "2023-506617-21-00",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2023-506617-21-00",
      "title": "A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for major depressive disorder compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment.",
      "substance": "ketamine",
      "phase": "Phase III",
      "conditions": "Major depressive disorder",
      "countries": [
        "Austria",
        "Germany",
        "Greece",
        "Italy",
        "Spain"
      ],
      "sites": [
        {
          "name": "Lwl-Klinik Dortmund",
          "city": "Dortmund",
          "psyaccess_url": "https://psyaccess.health/providers/lwl-klinik-dortmund/"
        },
        {
          "name": "Universitätsklinik für Psychiatrie und Psychotherapie Bielefeld",
          "city": "Bielefeld",
          "psyaccess_url": "https://psyaccess.health/providers/universitatsklinik-fur-psychiatrie-und-psychotherapie-bielefeld/"
        },
        {
          "name": "Westfaelische Wilhelms-Universitaet Muenster",
          "city": "Muenster",
          "psyaccess_url": "https://psyaccess.health/providers/westfaelische-wilhelms-universitaet-muenster/"
        },
        {
          "name": "Azienda Ospedaliera Universitaria Citta' Della Salute E Della Scienza Di Torino",
          "city": "Turin",
          "psyaccess_url": "https://psyaccess.health/providers/azienda-ospedaliera-universitaria-citta-della-salute-e-della-scienza-di-torino/"
        },
        {
          "name": "University Of Brescia",
          "city": "Brescia",
          "psyaccess_url": "https://psyaccess.health/providers/university-of-brescia/"
        },
        {
          "name": "Clinica Psichiatrica, 1st floor",
          "city": "Cagliari",
          "psyaccess_url": "https://psyaccess.health/providers/clinica-psichiatrica-1st-floor/"
        },
        {
          "name": "Hospital Clinic of Barcelona",
          "city": "Barcelona",
          "psyaccess_url": "https://psyaccess.health/providers/hospital-clinic-of-barcelona/"
        }
      ],
      "decision_date": "IT: 19/01/2024, ES: 22/01/2024, GR: 04/12/2024, DE: 17/01/2024, AT: 22/01/2024"
    },
    {
      "id": "2024-512559-20-01",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2024-512559-20-01",
      "title": "The additive effect of ketamine in combination with electroconvulsive stimulation (ECS) in major depressive disorder (MDD): a translational study",
      "substance": "ketamine",
      "phase": "Phase III",
      "conditions": "Major Depressive Disorder (MDD)",
      "countries": [
        "Italy"
      ],
      "sites": [
        {
          "name": "Ospedale San Raffaele S.r.l.",
          "city": "Milan",
          "psyaccess_url": "https://psyaccess.health/providers/ospedale-san-raffaele-s-r-l/"
        }
      ],
      "decision_date": "IT: 17/02/2025"
    },
    {
      "id": "2024-512672-34-00",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2024-512672-34-00",
      "title": "Comparison between esketamine nasal spray versus aripiprazole, both in combination with an antidepressant, in the refractory major depression disorder (RMDD) in elderly patients (CESAR)",
      "substance": "ketamine",
      "phase": "Phase III",
      "conditions": "Refractory major depression disorder (RMDD)",
      "countries": [
        "Spain"
      ],
      "sites": [
        {
          "name": "Fundació Hospitalàries Barcelona Nord",
          "city": "Barcelona",
          "psyaccess_url": "https://psyaccess.health/providers/fundacio-hospitalaries-barcelona-nord/"
        },
        {
          "name": "Fundació Hospitalàries Sant Boi",
          "city": "Sant Boi De Llobregat",
          "psyaccess_url": "https://psyaccess.health/providers/fundacio-hospitalaries-sant-boi/"
        },
        {
          "name": "Fundació Hospitalàries Martorell",
          "city": "Barcelona",
          "psyaccess_url": "https://psyaccess.health/providers/fundacio-hospitalaries-martorell/"
        },
        {
          "name": "Fundació Hospitalàries Sant Boi_Granollers",
          "city": "Granollers",
          "psyaccess_url": "https://psyaccess.health/providers/fundacio-hospitalaries-sant-boi-granollers/"
        },
        {
          "name": "Centro Sociosanitario Hermanas Hospitalarias de Palencia",
          "city": "Palencia",
          "psyaccess_url": "https://psyaccess.health/providers/centro-sociosanitario-hermanas-hospitalarias-de-palencia/"
        },
        {
          "name": "Clínica Psiquiátrica Padre Menni",
          "city": "Pamplona",
          "psyaccess_url": "https://psyaccess.health/providers/clinica-psiquiatrica-padre-menni/"
        },
        {
          "name": "Corporacion  Sanitaria Parc Tauli",
          "city": "Sabadell, Barcelona",
          "psyaccess_url": "https://psyaccess.health/providers/corporacion-sanitaria-parc-tauli/"
        },
        {
          "name": "Hospital Universitario Virgen del Rocio",
          "city": "Sevilla",
          "psyaccess_url": "https://psyaccess.health/providers/hospital-universitario-virgen-del-rocio/"
        },
        {
          "name": "Vall d'Hebron Hospital",
          "city": "Barcelona",
          "psyaccess_url": "https://psyaccess.health/providers/vall-d-hebron-hospital/"
        }
      ],
      "decision_date": "ES: 08/01/2025"
    },
    {
      "id": "2024-519097-39-01",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2024-519097-39-01",
      "title": "Ketamine for the treatment of depressive and negative symptoms in patients with schizophrenia: a randomized controlled cross-over pilot study.",
      "substance": "ketamine",
      "phase": "Phase III",
      "conditions": "Negative and depressive symptoms in schizophrenia / schizoaffective disorder",
      "countries": [
        "Austria"
      ],
      "sites": [],
      "decision_date": "AT: 27/02/2025"
    },
    {
      "id": "2023-508125-27-00",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2023-508125-27-00",
      "title": "Esketamine nasal spray (Spravato) for the treatment of therapy-resistant bipolar depression. An open-label pilot trial.",
      "substance": "ketamine",
      "phase": "Phase II",
      "conditions": "Bipolar disorder- depressive episode",
      "countries": [
        "Netherlands"
      ],
      "sites": [
        {
          "name": "Academisch Ziekenhuis Leiden",
          "city": "Leiden",
          "psyaccess_url": "https://psyaccess.health/providers/academisch-ziekenhuis-leiden/"
        }
      ],
      "decision_date": "NL: 26/11/2024"
    },
    {
      "id": "2024-512478-86-00",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2024-512478-86-00",
      "title": "Pharmacologic treatment augmentation in chronic depression\n“randomized, controlled, double blinded, phase II study”",
      "substance": "ketamine",
      "phase": "Phase II",
      "conditions": "Diagnosis of chronic depression",
      "countries": [
        "Germany"
      ],
      "sites": [
        {
          "name": "Universitaetsklinikum Tuebingen AöR",
          "city": "Tuebingen",
          "psyaccess_url": "https://psyaccess.health/providers/universitaetsklinikum-tuebingen-aor/"
        },
        {
          "name": "Universitaetsklinikum Jena KöR",
          "city": "Jena",
          "psyaccess_url": "https://psyaccess.health/providers/universitaetsklinikum-jena-kor/"
        },
        {
          "name": "LMU Klinikum Muenchen AöR",
          "city": "Munich",
          "psyaccess_url": "https://psyaccess.health/providers/lmu-klinikum-muenchen-aor/"
        }
      ],
      "decision_date": "DE: 10/04/2024"
    },
    {
      "id": "2023-506052-24-00",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2023-506052-24-00",
      "title": "Ketamine for combined depression and alcohol use disorder: A blinded randomized active placebo-controlled trial (the KeDA trial)",
      "substance": "ketamine",
      "phase": "Phase I/II",
      "conditions": "Depression, Alcohol use disorder",
      "countries": [
        "Norway"
      ],
      "sites": [
        {
          "name": "Universitetssykehuset Nord-Norge HF",
          "city": "Tromsoe",
          "psyaccess_url": "https://psyaccess.health/providers/universitetssykehuset-nord-norge-hf/"
        },
        {
          "name": "Østfold Hospital Trust",
          "city": "Grålum",
          "psyaccess_url": "https://psyaccess.health/providers/ostfold-hospital-trust/"
        }
      ],
      "decision_date": "NO: 23/02/2024"
    },
    {
      "id": "NCT05973851",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT05973851",
      "title": "Clinical trial",
      "substance": "ketamine",
      "phase": "",
      "conditions": null,
      "countries": [
        "Austria",
        "Italy"
      ],
      "sites": [
        {
          "name": "INTENSIFY MDD trial site — University of Cagliari",
          "city": "Cagliari",
          "psyaccess_url": "https://psyaccess.health/providers/intensify-mdd-trial-site-university-of-cagliari/"
        },
        {
          "name": "INTENSIFY MDD trial site — Università degli Studi della Campania Luigi Vanvitelli",
          "city": "Naples",
          "psyaccess_url": "https://psyaccess.health/providers/intensify-mdd-trial-site-universita-degli-studi-della-campania-luigi-vanvitelli/"
        },
        {
          "name": "INTENSIFY MDD trial site — AOU Città della Salute e della Scienza di Torino",
          "city": "Turin",
          "psyaccess_url": "https://psyaccess.health/providers/intensify-mdd-trial-site-aou-citta-della-salute-e-della-scienza-di-torino/"
        },
        {
          "name": "INTENSIFY MDD trial site — Medical University Innsbruck",
          "city": "Innsbruck",
          "psyaccess_url": "https://psyaccess.health/providers/intensify-mdd-trial-site-medical-university-innsbruck/"
        },
        {
          "name": "INTENSIFY MDD trial site — Università degli Studi di Brescia",
          "city": "Brescia",
          "psyaccess_url": "https://psyaccess.health/providers/intensify-mdd-trial-site-universita-degli-studi-di-brescia/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT07002684",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT07002684",
      "title": "Clinical trial",
      "substance": "ketamine",
      "phase": "",
      "conditions": null,
      "countries": [
        "Croatia"
      ],
      "sites": [
        {
          "name": "University of Zagreb School of Medicine (esketamine observational study)",
          "city": "Zagreb",
          "psyaccess_url": "https://psyaccess.health/providers/university-of-zagreb-school-of-medicine-esketamine-observational-study/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT07227454",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT07227454",
      "title": "Clinical trial",
      "substance": "ketamine",
      "phase": "",
      "conditions": null,
      "countries": [
        "Hungary"
      ],
      "sites": [
        {
          "name": "Petz Aladár Egyetemi Oktató Kórház (AVENUE trial)",
          "city": "Győr",
          "psyaccess_url": "https://psyaccess.health/providers/petz-aladar-egyetemi-oktato-korhaz-avenue-trial/"
        },
        {
          "name": "Szegedi Tudományegyetem (AVENUE trial)",
          "city": "Szeged",
          "psyaccess_url": "https://psyaccess.health/providers/szegedi-tudomanyegyetem-avenue-trial/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "2024-520305-39-00",
      "registry": "CTIS",
      "registry_url": "https://euclinicaltrials.eu/ctis-public/view/2024-520305-39-00",
      "title": "Efficacy and safety of minidosing lysergic acid diethylamide (LSD) for chronic cluster headache: a randomized placebo-controlled study",
      "substance": "lsd",
      "phase": "Phase II",
      "conditions": "Chronic cluster headache",
      "countries": [
        "Netherlands"
      ],
      "sites": [],
      "decision_date": "NL: 21/01/2025"
    },
    {
      "id": "NCT03781128",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT03781128",
      "title": "Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache",
      "substance": "lsd",
      "phase": "Phase II",
      "conditions": null,
      "countries": [
        "Switzerland"
      ],
      "sites": [
        {
          "name": "Clinical Pharmacology & Toxicology, University Hospital Basel",
          "city": "Basel",
          "psyaccess_url": "https://psyaccess.health/providers/clinical-pharmacology-toxicology-university-hospital-basel/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT05474989",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT05474989",
      "title": "LSD Treatment for Persons With Alcohol Use Disorder",
      "substance": "lsd",
      "phase": "Phase II",
      "conditions": null,
      "countries": [
        "Switzerland"
      ],
      "sites": [
        {
          "name": "University Hospital of Psychiatry, University of Basel",
          "city": "Basel",
          "psyaccess_url": "https://psyaccess.health/providers/university-hospital-of-psychiatry-university-of-basel/"
        },
        {
          "name": "University Hospital of Psychiatry, University of Bern",
          "city": "Bern",
          "psyaccess_url": "https://psyaccess.health/providers/university-hospital-of-psychiatry-university-of-bern/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT05477459",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT05477459",
      "title": "LSD to Improve Cluster Headache Impact Trial",
      "substance": "lsd",
      "phase": "Phase II",
      "conditions": null,
      "countries": [
        "Netherlands"
      ],
      "sites": [
        {
          "name": "Leiden University Medical Center (LUMC)",
          "city": "Leiden",
          "psyaccess_url": "https://psyaccess.health/providers/leiden-university-medical-center-lumc/"
        },
        {
          "name": "Canisius-Wilhelmina Ziekenhuis (CWZ)",
          "city": "Nijmegen",
          "psyaccess_url": "https://psyaccess.health/providers/canisius-wilhelmina-ziekenhuis-cwz/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT05883540",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT05883540",
      "title": "Lysergic Acid Diethylamide (LSD) in Palliative Care",
      "substance": "lsd",
      "phase": "Phase II",
      "conditions": null,
      "countries": [
        "Switzerland"
      ],
      "sites": [
        {
          "name": "University Hospital Basel, Division of Clinical Pharmacology and Toxicology",
          "city": "Basel",
          "psyaccess_url": "https://psyaccess.health/providers/university-hospital-basel-division-of-clinical-pharmacology-and-toxicology/"
        },
        {
          "name": "University Hospital Geneva, Palliative medicine department",
          "city": "Collonge-Bellerive",
          "psyaccess_url": "https://psyaccess.health/providers/university-hospital-geneva-palliative-medicine-department/"
        },
        {
          "name": "Spital Uster AG, Division of Internal Medicine",
          "city": "Uster",
          "psyaccess_url": "https://psyaccess.health/providers/spital-uster-ag-division-of-internal-medicine/"
        },
        {
          "name": "University Hospital Zurich, Clinic for Radio-Oncology, Competence Centre Palliative Care",
          "city": "Zurich",
          "psyaccess_url": "https://psyaccess.health/providers/university-hospital-zurich-clinic-for-radio-oncology-competence-centre-palliativ/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT07309471",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT07309471",
      "title": "Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD",
      "substance": "lsd",
      "phase": "",
      "conditions": null,
      "countries": [
        "Switzerland"
      ],
      "sites": [
        {
          "name": "University Hospital Basel",
          "city": "Basel",
          "psyaccess_url": "https://psyaccess.health/providers/university-hospital-basel/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT07444788",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT07444788",
      "title": "Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants",
      "substance": "dmt",
      "phase": "Phase I",
      "conditions": null,
      "countries": [
        "Switzerland"
      ],
      "sites": [
        {
          "name": "University Hospital Basel",
          "city": "Basel",
          "psyaccess_url": "https://psyaccess.health/providers/university-hospital-basel/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT05660642",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT05660642",
      "title": "Clinical trial",
      "substance": "dmt",
      "phase": "",
      "conditions": null,
      "countries": [
        "United Kingdom"
      ],
      "sites": [
        {
          "name": "MAC Clinical Research",
          "city": "Liverpool",
          "psyaccess_url": "https://psyaccess.health/providers/mac-clinical-research/"
        },
        {
          "name": "Hammersmith Medicines Research",
          "city": "London",
          "psyaccess_url": "https://psyaccess.health/providers/hammersmith-medicines-research/"
        },
        {
          "name": "King's College London, Clinical Trials Facility",
          "city": "London",
          "psyaccess_url": "https://psyaccess.health/providers/king-s-college-london-clinical-trials-facility/"
        }
      ],
      "decision_date": null
    },
    {
      "id": "NCT06927076",
      "registry": "ClinicalTrials.gov",
      "registry_url": "https://clinicaltrials.gov/study/NCT06927076",
      "title": "Antidepressant Response of DMT Masked With Propofol",
      "substance": "dmt",
      "phase": "",
      "conditions": null,
      "countries": [
        "Switzerland"
      ],
      "sites": [
        {
          "name": "University Hospital Basel",
          "city": "Basel",
          "psyaccess_url": "https://psyaccess.health/providers/university-hospital-basel/"
        }
      ],
      "decision_date": null
    }
  ]
}